Genentech pays $200M for Vaccibody's ... - Advanced Prostate...
Genentech pays $200M for Vaccibody's phase 1 cancer vaccine
Written by
fmenninger
To view profiles and participate in discussions please or .
2 Replies
•
Let me check behind the couch cushions for any loose change.....
Good Luck, Good Health and Good Humor.
j-o-h-n Friday 10/02/2020 6:37 PM DST
I wouldn't hold my breath - still at phase ONE after previous failures - an attempt to pursue / make progress / find the magic bullet.
Within this forum, there have been many 'mysterious' claims about something new / significant / offering hope - nothing new here, unfortunately.
Don't invest in this venture would be my advise, but I'm no doctor, of course ....
Not what you're looking for?
You may also like...
CANCER VACCINE
My husband saw his Oncol. last Fri. for his monthly treatment.
She mentioned that UCSF is doing a...
Niclosamide phase 1 b trial showing more promise for CRPC than phase 1 trial
It might also be of interest that a clinical trial is being funded to investigate whether the...
"Cholera Vaccine for Prostate Cancer Patients"
I'm 79. Diagnosed stage 4 prostate cancer, Gleason 9, in July 2017. Doing very well on...